These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8424594)

  • 21. Mechanisms of action of immune globulin.
    Fernández-Cruz E; Alecsandru D; Sánchez Ramón S
    Clin Exp Immunol; 2009 Sep; 157 Suppl 1(Suppl 1):1-2. PubMed ID: 19630862
    [No Abstract]   [Full Text] [Related]  

  • 22. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology].
    Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI
    Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880
    [No Abstract]   [Full Text] [Related]  

  • 23. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [General principles of antibiotic therapy and their use in the treatment of patients with immunologic deficiency syndromes].
    Altucci P; Abbate G
    Recenti Prog Med; 1974 Nov; 57(5):469-501. PubMed ID: 4375831
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunotherapy of high dose intravenous immunoglobulins: basic mechanisms of action and clinical implications].
    Korsak J; Kłos M
    Pol Arch Med Wewn; 2001 Nov; 106(5):1071-7. PubMed ID: 12026522
    [No Abstract]   [Full Text] [Related]  

  • 26. Subcorneal pustulosis with combined lack of IgG/IgM and monoclonal gammopathy type IgA/Kappa.
    Rasch A; Schimmer M; Sander CA
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):693-6. PubMed ID: 19243482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The question of when and how. Foreword.
    Alam R
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):xiii-xiv. PubMed ID: 18940568
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
    Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
    Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological evaluation of allergic respiratory children with recurrent sinusitis.
    Costa Carvalho BT; Nagao AT; Arslanian C; Carneiro Sampaio MM; Naspitz CK; Sorensen RU; Leiva L; Solé D
    Pediatr Allergy Immunol; 2005 Sep; 16(6):534-8. PubMed ID: 16176402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravenous inmunoglobulins in pediatrics].
    Panadero Esteban MI; Carcelén Andrés J; Urbieta Sanz E; Viñuales Armengol MC; Idoipe Tomás A
    Farm Hosp; 2003; 27(3):179-87. PubMed ID: 12835820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
    Romański B; Montowska L; Zbikowska-Götz M; Staszyńska M
    Pol Tyg Lek; 1985 Oct 7-14; 40(40-41):1139-42. PubMed ID: 3911181
    [No Abstract]   [Full Text] [Related]  

  • 33. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoglobulin replacement for selective IgM immunodeficiency, bronchiectasis, and asthma.
    Goldstein MF; Hilditch GJ; Dvorin DJ; Belecanech GA
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):172-3. PubMed ID: 26712522
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic rhinosinusitis and recurrent nasal polyps in two children with IgG subclass deficiency and review of the literature.
    Chinratanapisit S; Tunsuriyawong P; Vichyanond P; Visitsunthorn N; Luangwedchakarn V; Jirapongsananuruk O
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S251-8. PubMed ID: 16856448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
    J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibody deficiency syndrome in patients with lipid metabolism disorders].
    Storch H; König C; Reuter W
    Z Gesamte Inn Med; 1982 Sep; 37(17):567-70. PubMed ID: 7148055
    [No Abstract]   [Full Text] [Related]  

  • 38. Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(8):159-62. PubMed ID: 10079062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giardia lamblia infection in a patient with myotonic dystrophy.
    Mouthon L; Godmer P; Piqueras B; Cohen P; Lortholary O; Hofmann-Radvanyi H; Guillevin L
    Ann Med Interne (Paris); 2002 Dec; 153(8):540-2. PubMed ID: 12610429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summary.
    Ballow M
    J Clin Immunol; 2012 Sep; 32 Suppl 2():S409. PubMed ID: 22526596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.